Studies from Seoul National University College of Medicine Provide New Data on Cancer (Fadraciclib, a CDK2/CDK9 inhibitor, shows efficacy in biliary tract cancer and synergistic potential with olaparib and JQ1 based on MCL1 expression)

Media coverage

• Title	Studies from Seoul National University College of Medicine Provide New Data on Cancer (Fadraciclib, a CDK2/CDK9 inhibitor, shows efficacy in biliary tract cancer and synergistic potential with olaparib and JQ1 based on MCL1 expression)
  Media name/outlet	Genomics & Genetics Daily
  Country/Territory	United States
  Date	25.12.29
  Persons	Min-Gul Kim, Min Sik Kim, Jung-Mu Kim